Aarkstore -Partial Seizure-Pipeline Insights, 2014

1
Partial Seizure-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77317/-partial
  -seizure-pipeline-insights-2014

2
Summary

• DelveInsights, Partial Seizure-Pipeline Insights,
  2014, report provides comprehensive insights
  about pipeline drugs across this indication. A
  key objective of the report is to establish the
  understanding for all the pipeline drugs that
  fall under Partial Seizure. This report provides
  information on the therapeutic development based
  on the Partial Seizure dealing with all the
  pipeline drugs, comparative analysis at various
  stages covering Filed, Phase III, Phase II, Phase
  I, IND filed, Preclinical, Discovery and unknown
  stages, therapeutics assessment by monotherapy
  and combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Partial SeizureThe
  report provides pipeline products under drug
  profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Partial Seizure
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Partial Seizure
  and also provide company profilingThe report
  also gives the information of dormant and
  discontinued pipeline projects Pipeline products
  coverage based on various stages of development
  ranging from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Partial Seizure
• Identify the relationship between the drugs and
  use it for target finding, drug repurposing, and
  precision medicine.
• Devise corrective measures for pipeline projects
  by understanding Partial Seizure pipeline depth
  and focus of Indication therapeutics
• Developing strategic initiatives to support your
  drug development activities.
• Optimize your portfolio and keep you in touch
  with the rapidly changing pharmaceutical markets,
  and make the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline
• Gaining a Full Picture of the Competitive
  Landscape for Evidence based Decisions

7
Table of Content

• Partial Seizure OverviewPartial Seizure Pipeline
  TherapeuticsPartial Seizure Therapeutics under
  Development by Companies Partial Seizure Late
  Stage Products (Filed and Phase III)Comparative
  Analysis Partial Seizure Mid Clinical Stage
  Products (Phase II)Comparative Analysis Partial
  Seizure Early Clinical Stage Products (Phase I
  and IND Filed)Comparative Analysis Partial
  Seizure Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles

8
Table of Content

• Partial Seizure Therapeutics Assessment Assessmen
  t by Monotherapy Products Assessment by
  Combination Products Assessment by Route of
  Administration Assessment by Molecule
  Type Partial Seizure Discontinued
  Products Partial Seizure Dormant
  ProductsCompanies Involved in Therapeutics
  Development for Partial Seizure Appendix Methodo
  logy Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Partial
  Seizure, 2014Number of Products under
  Development by Companies Comparative Analysis by
  Late Clinical Stage Products (Filed and Phase
  III), 2014Comparative Analysis Mid Clinical
  Stage Products (Phase II), 2014Comparative
  Analysis Early Clinical Stage Products (Phase I
  and IND Filed), 2014Comparative Analysis
  Discovery and Pre-Clinical Stage Products,
  2014Drug Candidates ProfilesPartial Seizure
  Assessment by Monotherapy Products Partial
  Seizure Assessment by Combination
  Products Partial Seizure Assessment by Route of
  Administration 

10
List of Tables

• Partial Seizure Assessment by Stage and Route of
  Administration Partial Seizure Assessment by
  Molecule Type Partial Seizure Assessment by
  Stage and Molecule Type Partial Seizure
  Therapeutics Discontinued Products Partial
  Seizure Therapeutics Dormant ProductsProducts
  under Development by Companies, 2014

11
List of Figures

• Number of Products under Development for Partial
  Seizure, 2014Late Clinical Stage Products (Filed
  and Phase III), 2014Mid Clinical Stage Products
  (Phase II), 2014Early Clinical Stage Products
  (Phase I and IND Filed), 2014Discovery and
  Pre-Clinical Stage Products, 2014Partial Seizure
  Assessment by Monotherapy Products Partial
  Seizure Assessment by Combination
  Products Partial Seizure Assessment by Route of
  Administration Partial Seizure Assessment by
  Stage and Route of Administration Partial
  Seizure Assessment by Molecule Type Partial
  Seizure Assessment by Stage and Molecule Type

12
Related Reports

• Laboratory Information Management Systems/ LIMS
  Market by Product (COTS Legacy), Delivery Mode
  (On-premise, Hosted, Cloud), Component (Software
  Services), End User Industries (Healthcare,
  CRO, Petrochemical, Oil and Gas, Chemical) -
  Forecast to 2019
• 2015 Worldwide Nursing Care Facilities
  Industry-Industry Market Report
• 2015 Worldwide Medical Surgical Hospitals
  Industry-Industry Market Report
• 2015 Worldwide Home Health Care Services
  Industry-Industry Market Report
• 2015 Worldwide Offices of Dentists
  Industry-Industry Market Report
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review

13

• Partial Seizure-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Partial Seizure-Pipeline Insights,
  2014, report provides comprehensive insights
  about pipeline drugs across this indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news